Northeast Epilepsy Group

Clinical research site in Hackensack, New Jersey · NE Regional Epilepsy Group, 20 Prospect Ave #800, Hackensack, NJ 07601 · (201) 343-6676 · Website

As of July 2026, 6 paid clinical trials are recruiting at Northeast Epilepsy Group in Hackensack, New Jersey. Active studies at this site cover conditions such as Focal Onset Seizures, KCNT1-Related Epilepsy and Lennox Gastaut Syndrome. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Northeast Epilepsy Group (6)

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

for Primary Generalized Tonic-Clonic Seizures

51 locations incl. Mobile

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 12+

Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for GRIN-related Neurodevelopmental Disorder

17 locations incl. Los Angeles

Sponsor: GRIN Therapeutics, Inc.

Sex: All·Age: 1 Month - 18

Code: NCT07224581·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

for Mesial Temporal Lobe Epilepsy

18 locations incl. Birmingham

Sponsor: UniQure Biopharma B.V.

Sex: All·Age: 18 - 75

Code: NCT06063850·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

for Focal Onset Seizures

17 locations incl. Little Rock

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT05716100·Phase 3·Recruiting·Listed Feb 2023

Apply to this trial

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

for Seizures

7 locations incl. Palo Alto

Sponsor: SK Life Science, Inc.

Sex: All·Age: 4 - 55

Code: NCT05219617·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric Participants With KCNT1-related Epilepsy

for KCNT1-Related Epilepsy

1 location in Hackensack

Sponsor: Actio Biosciences, Inc.

Sex: All·Age: 1 Month - 21

Code: NCT07600736·Phase 2·Recruiting·Listed May 2026

Apply to this trial

More research sites in Hackensack

Hackensack University Medical Center (123 trials)
John Theurer Cancer Center at Hackensack University Medical Center (41 trials)
John Theurer Cancer Center (12 trials)
Hackensack Meridian Health (10 trials)
John Theurer Cancer Center at Hackensack UMC (7 trials)
John Theurer Cancer Center Hackensack University Medical Center (6 trials)
Northeast Regional Epilepsy Group (5 trials)
Hackensack Meridian Health - Hackensack University Medical Center (5 trials)
Hackensack Meridian Health (Data collection only) (4 trials)
Hackensack Medical Center (3 trials)

Explore more

Paid clinical trials in Hackensack, NJ · New Jersey clinical trials